Spyre Therapeutics, Inc. (NASDAQ:SYRE) Sees Significant Decrease in Short Interest
Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 10,069,741 shares, a...